Hematology Analyzers Market
Global Market Study on Hematology Analyzers: High Focus on Innovation in Devices to Aid Market Expansion
Hematology Analyzers Market Segmented By Standalone, Point of care Modality in Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Blood Banks
Leading industry players are focusing on innovation-based ideas, leveraging scientific development opportunities with technological advancements in the field of diagnostics and testing. Introduction of new advancements in technology and the evolution of software for cellular analysis have resulted in an improvement in analytic efficiency and data management.
Advanced hematology analyzers are able to provide more information, both, quantitative and qualitative, such as the suspect flags (used to detect errors). Real-time graphical data provides information regarding abnormal cell population and disease patterns, which improves efficiency.
3D is expected to be an emerging innovation zone for many players. For instance, Mindray’s SF cube technology has emerged, which targets blood cells by using the bi-angular laser scatter signals and fluorescence signals and generates 3D scattergrams that provide cellular information. Furthermore, automation has increased opportunities in the hematology analyzers market by leading to advancements in instruments such as incorporation of automated ESR (erythrocyte sedimentation rate) systems, integral slide-makers, HbA1c systems, tube sorters, and digital morphology systems, linked to middleware. All these factors bode well for the expansion of the hematology analyzers market size over the next ten years.
Find Out More about the Report Coverage
- SYSMEX CORPORATION
- Abbott Laboratories
- Beckman Coulter Inc
- Siemens AG
- Boule Diagnostics AB.
- Nihon Kohden Corporation
- HORIBA, Ltd.
- Edan Instruments, Inc.
- Biosystems S.A
- F. Hoffmann-La Roche Ltd.
- Shenzhen Dymind Biotechnology Co.,Ltd
- PZ CORMAY S.A.
- Shenzhen Landwind Industry Co., Ltd
- Rayto Life and Analytical Sciences Co., Ltd.
- Shenzhen Prokan Electronics Lnc.
Increasing Awareness Regarding Chronic Diseases to Drive Market Growth
Increasing awareness regarding chronic diseases across the world is expected to boost revenue growth of the hematology analyzers market over the forecast period. Chronic diseases are the leading cause of death with high prevalence. Disease rate from these conditions is accelerating globally, advancing across every part of the globe and affecting all socio-economic classes. To control the progress of such diseases, healthcare is strongly focused toward the early detection and cure of such conditions.
Blood analysis has gained popularity over time for the early detection of many chronic diseases, which was earlier only possible by tissue biopsy tests. Advancements in blood markers for diseases have a significant role in the advancement of the hematology analyzers market.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Regional Outlook of Hematology Analyzers Market
North America clearly dominates the hematology analysers market share, and is expected to continue to do so through the forecast period. However, emergence of local players and availability of cheaper automated hematology devices in the East Asia region will support its rapid growth during the forecast period. While adoption of advanced technology drives the growth of the hematology analyzers market in North America, rising prevalence of diseases and ageing population in East Asia are key drivers for this regional market.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
COVID-19 Impact on Hematology Analyzers Market
The COVID-19 outbreak has affected the global economy in several ways, such as limited care units and labor shortage, disruptions in supply chains, lack of raw materials, and reduced transportation, especially in the first two quarters of 2020. However, in the last two quarters of 2020, sales are expected to pick pace and cover for the losses in the beginning of the year. However, increasing use of hematology analyzers for research on COVID could result is a small peak in the year-on-year growth in 2020. As a whole, the COVID-19 will not have a significant impact on the hematology analyzers market.
Explore Persistence Market Research’s expertise in promulgation of the business !
Competition Outlook of Hematology Analyzers Market
The hematology analyzers market is characterized as a consolidate market space, with the top players holding over 70% of the hematology analyzers market share. Most players are strongly focused on the development of innovative products. The past decade has witnessed the launch of 6-part and 4-part hematology analyzers that offer more products to end users to match their requirements. Along with this, there is significant focus on the development of additional features and automation of devices such as 3D scatter maps and suspect mapping. Collaborations with distributors is also another key focus of players in the hematology analyzers market that will offer better penetration of products throughout the world.
An extensive analysis of the hematology analyzers market has brought our analysts to a conclusion that, 5-part hematology analyzers will continue to dominate the market globally. While point of care devices are experiencing a surged demand, standalone devices will hold a larger chunk in 2020. Collaborations with distributors, and launch of new products with emphasis on development of innovative devices, are key focus areas of top players in the market that will significantly boost growth through the forecast period.